Literature DB >> 10903003

Review article: gall-bladder motor function in obesity.

M L Petroni1.   

Abstract

A number of epidemiological studies has established obesity as a risk factor for gallstone disease. More recently, studies have suggested a relationship between gallstone disease and the metabolic syndrome linked to central adiposity, whose cardinal feature is represented by hyperinsulinaemia. Studies on fasting gall-bladder volume in obese subjects show that this parameter correlates with weight, body mass index (BMI) and body surface area; however, this is also true for large-sized non-obese subjects. Gall-bladder volume also correlates with abdominal fat and with impaired glucose tolerance. In contrast to the well-established role of bile supersaturation in the pathogenesis of gallstones in obesity, data are controversial on whether gall-bladder motor function is defective in obese subjects. However, studies were heterogeneous for subjects' BMI, emptying stimulus, technique used and parameters assessed to evaluate gall-bladder motor function. Also, differences in baseline gall-bladder volume may lead to wide differences in bile 'washout' effect despite apparently similar percentage changes in volume or content. Although post-prandial plasma levels of cholecystokinin (CCK) are normal in obese subjects, there is some evidence that a sub-group of obese subjects could have decreased sensitivity to CCK, possibly mediated by hyperinsulinaemia. Further studies using standard physiological stimuli and controlling for glucose tolerance, fasting insulin levels and baseline gall-bladder volume are needed to establish the role of gall-bladder motor function in the pathogenesis of gallstone disease in obesity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903003     DOI: 10.1046/j.1365-2036.2000.014s2048.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  9 in total

Review 1.  Management of gallstones and gallbladder disease in patients undergoing gastric bypass.

Authors:  Bernabé M Quesada; Gustavo Kohan; Hernán E Roff; Carlos M Canullán; Luis T Chiappetta Porras
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

2.  Relationship between weight loss and gallbladder motility in obese women.

Authors:  Ramazan Sari; Mustafa Kemal Balci
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

3.  Gastrointestinal issues in the assessment and management of the obese patient.

Authors:  Zulfiqar Hussain; Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-07

4.  Gallbladder motor function, plasma cholecystokinin and cholecystokinin receptor of gallbladder in cholesterol stone patients.

Authors:  Jian Zhu; Tian-Quan Han; Sheng Chen; Yu Jiang; Sheng-Dao Zhang
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

5.  Construction and Evaluation of a Nomogram to Predict Gallstone Disease Based on Body Composition.

Authors:  Jian-Hui Lu; Gen-Xi Tong; Xiang-Yun Hu; Rui-Fang Guo; Shi Wang
Journal:  Int J Gen Med       Date:  2022-07-02

Review 6.  Steatocholecystitis and fatty gallbladder disease.

Authors:  Chung-Jyi Tsai
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

7.  Anthropometric measurements, physical activity, and the risk of symptomatic gallstone disease in Chinese women.

Authors:  Lifang Hou; Xiao-Ou Shu; Yu-Tang Gao; Bu-Tian Ji; Jocelyn M Weiss; Gong Yang; Hong-Lan Li; Aaron Blair; Wei Zheng; Wong-Ho Chow
Journal:  Ann Epidemiol       Date:  2009-05       Impact factor: 3.797

8.  Clinical Relationship between Steatocholecystitis and Gallbladder Contractility Measured by Cholescintigraphy.

Authors:  Chang Seok Bang; Yong Sub Lee; Jai Hoon Yoon; Youn Jeong Kim; Jin Bong Kim; Dong Joon Kim
Journal:  Gastroenterol Res Pract       Date:  2015-01-29       Impact factor: 2.260

9.  Effects of liraglutide on gallbladder emptying: A randomized, placebo-controlled trial in adults with overweight or obesity.

Authors:  Christina C Nexøe-Larsen; Pernille H Sørensen; Helene Hausner; Mikkel Agersnap; Mille Baekdal; Andreas Brønden; Lea N Gustafsson; David P Sonne; Louise Vedtofte; Tina Vilsbøll; Filip K Knop
Journal:  Diabetes Obes Metab       Date:  2018-07-10       Impact factor: 6.577

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.